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Abstract Fatty acid amide hydrolase contains a proline-rich
sequence matching a consensus sequence for SH3-binding
domains as well as a transmembrane domain. In this study,
deletion mutants lacking the proline-rich region and the
transmembrane domain were generated. Transfection experi-
ments demonstrated that the proline-rich deleted amidase was
enzymatically inactive. While immunostaining of the wild-type
was always punctate with strong perinuclear staining character-
istic for endoplasmic reticulum, the staining of the mutant was
diffuse and distributed throughout the cytoplasm and perinuclear
region. These observations along with the loss of activity suggest
that the proline-rich region may play a role in the subcellular
localization and enzymatic function. The transmembrane do-
main-deleted mutant was indistinguishable from the wild-type
enzyme.
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1. Introduction
Anandamide amidase, fatty acid amide hydrolase (FAAH),
is the enzyme responsible for hydrolysis of neuromodulatory
fatty acid amides and esters such as anandamide, 2-arachidon-
yl glycerol and oleamide [1^3]. This hydrolase contains a pro-
line-rich sequence which may bind to Src homology 3 domain
(SH3) of another protein [2]. SH3 domains regulate protein
localization, enzymatic activity and may participate in multi-
component signaling complexes [4]. Examples of such inter-
actions have been described for PLCQ [5], the epithelial so-
dium channel [6], myosin [7] and dynamin [8^10] and the
dopamine D4 receptor [11]. It has been shown that removal
of the proline-rich region abolishes interactions that prevent
assembly of proteins and/or interferes with the normal func-
tion of proteins. For example, the proline-rich domain of the
GTPase dyanamin has shown to be involved in localization in
coated pits and in GTP-binding activity [12]. To understand
the relevance of the proline-rich domain in the FAAH func-
tion, we constructed a deletion mutant lacking the polyproline
region (amino acids 307-PTVPPLPFR-315) and assayed it for
enzymatic activity, membrane association and immunolocali-
zation in COS-7-transfected cells. Primary sequence analysis
also detected a transmembrane domain from amino acids 9-
TLSGVSGVCLACSLLSAAVVL-29 which may function as a
site for insertion into the membrane and/or oligomerization of
the amidase [2,13]. We constructed a mutant lacking this
transmembrane region and characterized it in transfected
COS-7 cells for the activity, expression pattern and distribu-
tion into membrane and soluble fractions.
2. Materials and methods
2.1. Deletion of the proline-rich domain (vPR-FAAH)
The deletion mutant was generated from the cloned rat FAAH
cDNA by PCR as follows. The FAAH open reading frame was am-
pli¢ed in two fragments using the following primers. For fragment I,
sense primer 5P-GAGAATTCATGGTGCTGAGCGAAG-3P contain-
ing an EcoRI site and antisense primer 5P-CCGCTCGAGGTC-
CAAGGTGAACAAG-3P containing a XhoI site. For fragment II,
sense primer 5P-CCGCTCGAGTATAGAAGTTCTAGACCC-3P con-
taining a XhoI site and antisense primer 5P-TAGAATTCCGATGG-
CTGCTTTTGAG-3P. Two PCR products, 918 bp and 782 bp, were
generated, digested with XhoI and ligated. The ligation product was
subcloned into the EcoRI site of pBSKII. The construct was digested
with HindIII/XbaI to generate a 390 bp fragment containing the dele-
tion and the fragment was then subcloned into the wild-type construct
vpcDNA3-FAAH (this construct is the FAAH cDNA cloned into a
pcDNA3 vector that has a modi¢ed polylinker to facilitate subclon-
ing, see construction below). The vPR-FAAH mutant construct was
con¢rmed by DNA sequencing.
2.2. Construction of the transmembrane domain deletion
(vHDI-FAAH)
A mutant lacking the N-terminal hydrophobic domain (amino acids
9^29) was constructed by PCR as follows. The plasmid vpcDNA3-
FAAH was ampli¢ed in two fragments using the following primers.
For fragment I, sense primer 5P-CGAAATTAATACGACTCAC-3P
and antisense primer 5P-CTTGGATCCGGTCCACACTTCG-3P, the
antisense primer contained a BamHI site. For fragment II, the sense
primer was 5P-GAGGATCCCGATGGACCGGG-3P and antisense
primer 5P-TAGAATTCCGATGGCTGCTTTTGAG-3P and the sense
primer contained a BamHI site. Two PCR products were generated,
digested with BamHI and ligated. The ligation product was subcloned
into the EcoRI site of pBSKII. The construct was digested with
EcoRI/HindIII to generate a 644 bp fragment containing the deletion.
This mutant fragment was subcloned into the wild-type construct
vpcDNA3-FAAH. The construct was veri¢ed by DNA sequencing.
2.3. Construction of vpcDNA3 expression vector
To facilitate subcloning of mutant fragments, the expression vector
pcDNA3 (Invitrogen) was double-digested with HindIII/XbaI to re-
move all but one EcoRI cloning site. The digestion product was ¢lled-
in with Klenow and the blunt-end plasmid was religated and trans-
formed into XL-1 blue competent cells. The plasmid was digested with
ApaI, dephosphorylated and ligated to phosphorylated ApaI/EcoRI
adapters. The resulting plasmid is a pcDNA3 with a unique EcoRI
cloning site. The construct was veri¢ed by restriction analysis. FAAH
cDNA was cloned as an EcoRI fragment into this vector (vpcDNA3-
FAAH).
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2.4. Cell culture and transfections
COS-7 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% fetal bovine serum and L-glutamine (complete
DMEM) at 37‡C and 5% CO2 atmosphere to 70% con£uence. Cells
were transiently transfected with wild-type and mutant constructs us-
ing lipofectamine (Gibco BRL) in serum-free DMEM. After 5 h in-
cubation, complete medium was added and cells were further incu-
bated for 36 h prior to analysis.
2.5. Preparation of cellular membranes
Cells were rinsed once in phosphate-bu¡ered saline (PBS, 150 mM
NaCl, 20 mM sodium phosphate, pH 7.4) and then lysed in 20 mM
Tris, pH 9.0, 1 mM EDTA. Lysates were homogenized in the presence
of protease inhibitors as described [14]. The particulate fraction was
collected by centrifugation of the lysates at 100 000Ug for 30 min.
Pellets were resuspended and homogenized in lysis bu¡er. Total pro-
tein from supernatant and pellet fractions was determined using the
Bradford method (Bio-Rad).
2.6. Anandamide amidase assay
Enzymatic activity was measured as previously described [15] with
some modi¢cations. Brie£y, samples were incubated with 30 WM
anandamide containing 0.01 WCi of arachidonoyl ethanolamide [1,2-
14C]ethanolamine (120 mCi/mmol) in 0.1 M Tris, pH 9.0, 2.5 mg/ml
defatted BSA, for 30 min at 37‡C. Reactions were terminated by
addition of two volumes of methanol:chloroform (1:1) and radioac-
tivity was measured by scintillation counting of the aqueous phase.
2.7. Polyacrylamide gel electrophoresis (PAGE) and Western
immunoblotting
SDS-PAGE was performed according to Laemmli after dissolving
samples in 5Uloading bu¡er. Proteins were separated on 10% poly-
acrylamide gels using the Mini-Protean II system (Bio-Rad). Proteins
were transferred to a PVDF membrane (Millipore) using a mini
Trans-Blot apparatus (Bio-Rad) under conditions recommended by
the manufacturer. Blots were blocked in PBS containing 0.1% Tween
20 and 5% non-fat dried milk for 1 h. Blots were incubated with
rabbit anti-FAAH antibodies, a gift of Benjamin Cravatt, and then
with horseradish peroxidase-conjugated goat anti-rabbit IgG. Immu-
noreactive bands were visualized by enhanced chemiluminescence
(Amersham).
2.8. Immuno£uorescence
COS-7 cells were grown on polylysine-coated coverslips and were
transfected as described above. Cells were ¢xed in PBS containing 3%
paraformaldehyde for 30 min at room temperature, permeabilized
with 1% Triton X-100 in PBS and blocked with PBS containing 10
mM glycine and 1% bovine serum albumin. Cells were incubated with
polyclonal anti-FAAH antibodies and then with £uorescein-conju-
gated goat anti-rabbit IgG, each for 30 min at room temperature.
Coverslips were mounted using a Slow Fade Anti Fade kit (Molecular
Probes) before visualization by £uorescence microscopy. Anti-calnexin
amino-terminal polyclonal antibody was obtained from StressGen
Biotechnologies (Victoria, B.C., Canada).
3. Results and discussion
A deletion mutant lacking amino acids 307^316 encoding
the consensus class II SH3-binding domain sequence [2,16]
was generated by PCR as described. A HindIII/XbaI fragment
containing the deletion was subcloned into the expression
construct vpcDNA3-FAAH. As a control, the HindIII/XbaI
wild-type fragment was subjected to the same manipulations
as the mutant. All constructs were veri¢ed by DNA sequenc-
ing. When expressed in COS-7 cells, both the wild-type, and
proline deletion mutant, vPR, migrated at an apparent mo-
lecular weight of approximately 64 kDa (Fig. 1A). Although
the vector had some bands which cross-reacted with the anti-
body near this region, they were light staining and were
equally detectable in the soluble and particulate fractions
(data not shown). However, when the membranes are probed
with pre-absorbed antibody against non-transfected cell ly-
sate, only the band near 64 kDa is observed in the particulate
fraction (Fig. 1A). As with the wild-type, the vPR mutant
always associated with the particulate fraction from homoge-
nates of transiently transfected COS-7 cells (Fig. 1A). There-
fore, the proline-rich region does not a¡ect the association of
FAAH with soluble or membrane fractions. This is not true in
the case of the synaptojanins, for example, where the nature
of the proline-rich region determines whether the protein is
localized to particulate or soluble fractions [17]. As shown on
the SDS-PAGE Western blot in Fig. 1B, deletion of a trans-
membrane region (amino acids 9^29) did not result in the
release of signi¢cant soluble form of the enzyme in transfected
COS-7 cells either. Like the wild-type, the hydrophobic dele-
tion mutant (vHD1) was detected mainly in the particulate
fraction. Anandamide amidase is a membrane-associated en-
Fig. 1. Western blot analysis of soluble (S) and (P) particulate frac-
tions from COS-7 cells transfected with (A) vpcDNA3-FAAH
(WT), the mutant lacking the proline-rich region (vPR) and
vpcDNA3 (vector) and (B) vector, wild-type FAAH and the vHDI
mutant. The arrow denotes the position of the 64 kDa molecular
weight marker.
Fig. 2. Enzymatic activity of soluble (S) and (P) particulate fractions
from COS-7 cells transfected with (A) vector, wild-type FAAH
(WT) and the vPR-FAAH mutant (vPR) and (B) vector, wild-type
FAAH (WT) and the vHDI-FAAH mutant (vHDI).
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zyme while the other amidases in this family, with which it
shares homology, are water soluble enzymes [13,18,19]. This
membrane association is perhaps essential considering the hy-
drophobicity of its substrates. From the above experiments,
we conclude that neither the proline-rich region or transmem-
brane region are in themselves responsible for this enzyme’s
strong association with the membrane. It is likely that deletion
of the transmembrane region is not su⁄cient to ‘solubilize’ the
amidase because of other regions which also interact with the
membrane.
The enzymatic activity of the wild-type enzyme is also
strongly associated with the membrane with only background
detected in the soluble fraction as shown in Fig. 2A. Interest-
ingly, deletion of the proline-rich region completely abolished
the enzymatic activity from the particulate fraction. This is
not due to lower levels of vPR-FAAH, in transfected COS-
7 cells, since the expression of the vPR-FAAH mutant was as
robust as that observed for the wild-type FAAH (Fig. 1A).
Unlike the situation with the proline-rich region, deletion of
the transmembrane domain had no e¡ect upon the activity in
the particulate fraction (Fig. 2B). Only a small amount of
enzymatic activity was observed in the soluble fraction of
vHDI, suggesting little release of the enzyme from the mem-
brane. From these studies, we conclude that the proline-rich
domain is essential for FAAH activity while the amino acids
9^29 in the hydrophobic region are not important for catalytic
activity. These results are in agreement with those reported
where the N-terminal 29 amino acids were truncated and the
puri¢ed enzyme had identical enzymatic properties to the na-
tive enzyme except for loss of the ability of the mutated en-
zyme to self-hybridize [13]. Under the concentrations used for
our experiments, we did not observe a signi¢cant amount of
dimers or other higher molecular weight species in SDS-
PAGE gels, especially if the antibody was pre-absorbed with
untransfected cell lysate proteins.
To investigate whether the proline-rich region and trans-
membrane region have a role in FAAH subcellular localiza-
tion, we examined expression of wild-type (WT-) FAAH,
vPR-FAAH and vHD1-FAAH in COS-7 cells by indirect
immuno£uorescence analysis (Fig. 3). The pattern of expres-
sion of WT-FAAH and vHDI-FAAH were indistinguishable.
However, cells transiently transfected with the vPR-FAAH
mutant were quite di¡erent. Staining of WT-FAAH was al-
ways punctate with strong perinuclear staining characteristic
for the endoplasmic reticulum. The similarity of the staining
we observed to that reported for an endoplasmic reticular
pattern of expression was veri¢ed by immunostaining of the
FAAH-transfected COS-7 cells with anti-calnexin (data not
shown). This antibody is speci¢c for calnexin which is an
endoplasmic reticulum transmembrane protein [20]. Our im-
muno£uorescence results for the WT-FAAH appear to be
very much like those recently reported for COS-7 cells ex-
pressing the rat FAAH [21]. In contrast, staining of vPR-
FAAH was not punctate in character, but rather di¡use in
the cytoplasm and the perinuclear region. The vector-trans-
fected COS-7 cells exhibited only very light staining (Fig. 3).
These observations along with the loss of activity suggest that
the proline-rich region may play a role in subcellular local-
ization and might be important for the enzymatic function.
SH3 domains bind to target proteins by associating with
proline-rich motifs and mediate protein-protein interactions
to regulate subcellular localization. Gout et al. [8] showed
that dynamin, a GTPase implicated in synaptic vesicle endo-
cytosis and recycling, binds to and is activated by several SH3
domain-containing proteins. The observation that SH3 do-
mains are able to stimulate the rate of GTP hydrolysis on
Fig. 3. Immuno£uorescence of COS-7 cells transfected with WT-FAAH, vPR-FAAH, vHDI-FAAH and vector stained with anti-FAAH anti-
body. An insigni¢cant amount of staining was observed in untransfected cells. Magni¢cation, 630-fold. These data are representatives of at least
three separate transfections for each expression construct and observations of approximately 100 cells from each.
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dynamin directly was the ¢rst indication that these domains
are not only involved in protein-protein interaction but they
can also regulate the function of associated molecules. Fur-
thermore, recently, it has been demonstrated that amphiphys-
in, a binding partner for dynamin I in nerve terminals, binds
with high a⁄nity to a unique site in its proline-rich domain
and that the SH3-binding motif of dynamin is required for its
targeting to clathrin-coated pits [8,9,22]. Amphiphysin, which
interacts with the clathrin adapter AP2, may play a role in the
recruitment of dynamin I at clathrin-coated pits involved in
synaptic vesicle formation. It has also been shown that the
proline-rich domain of dynamin I undergoes phosphorylation/
dephosphorylation [23]. It is possible that phosphorylation
may serve to regulate the interactions of dynamin with the
SH3 domain of amphiphysin.
Our results suggest further experiments to study the possi-
ble binding partners for FAAH and a possible role for phos-
phorylation of a speci¢c threonine residue present in its pro-
line-rich motif. To better understand the role of FAAH in the
metabolism of the neuromodulator anandamide, it is impor-
tant to determine if proline-rich domain-mediated interactions
are required for localization of the enzyme at the site of action
and/or if these interactions are somehow involved in regula-
tion of the enzyme function. It is possible that the proline-rich
region may play an essential role in the correct folding of the
amidase and its deletion results in loss of enzymatic activity
and a modi¢ed intracellular localization. However, it is inter-
esting to note that a sequence similar to PTVPPLPFR is not
found in the other non-mammalian members of the amidase
family, but does occur in many other unrelated proteins. Also,
we cannot rule out that overexpression of FAAH in COS-7
may saturate normal compartments. It is important to see if
the same observations can be extended to cells naturally ex-
pressing the enzyme. The localization of the enzyme to the
endoplasmic reticulum is consistent with the observation that
the enzyme has been reported to be mainly microsomal (mi-
crosomes are pinched o¡ endoplasmic reticular membranes) in
nature [1,24,25]. The study of FAAH-binding partners and
analysis of its post-translational modi¢cations may help to
elucidate its role in the regulation of the endocannabinoids.
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